News
News
PublISHED ON
UpDATED ON
Swedish Research Council allocates 25 million SEK to platform for antibiotics development
The Swedish Research Council has decided to allocate 26 million SEK to fund ENABLE-2, a platform for developing antibiotics at Uppsala University, during 2021–2022.
The platform opened on 4 October for new applications. The research to be funded via the platform shall relate to molecules that may be candidates for antibacterial medicines. With support from Vinnova, companies may also apply to use the platform.
See the call from ENABLE-2 for further information.
External link.
MORE WITHIN THE SAME SUBJECT AREA
-
Activity |
Published 31 January 2022
On 3 February, JPIAMR organises an international conference to discuss and shape a new partnership with a so-called "One Health" perspective. The conference is aimed at the research community, research policy actors as well as the public and private ...
-
News |
Published 18 November 2021
To safeguard the world’s supply of effective medicines, we need large resources for research and innovation, broad-based global collaboration and clear leadership. Sweden plays a leading role in the international efforts against antibiotic resistance...
Keywords:
-
News |
Published 17 November 2021
We tend to underestimate the role played by the environment when it comes to spreading antibiotic resistance. Limiting resistance in poor countries is central for limiting future problems in other countries too. This is the view of Joakim Larsson, wh...
Keywords: